首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine
【24h】

Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine

机译:中医治疗冠心病中Circrna-miRNA-mRNA网络的研究进展

获取原文
           

摘要

There has been an increase in morbidity and mortality related to coronary heart disease (CHD) in China in recent years. Numerous clinical experiences and studies have shown that traditional Chinese medicine (TCM) plays an important role in the prevention, treatment, and prognosis of CHD. However, the mechanism of TCM in the treatment of CHD has not yet been elucidated. The circRNA-miRNA-mRNA network consists of miRNA that is competitively bound by circRNA, and miRNA regulates the transcription level of mRNA. Through literature review, we found that the circRNA-miRNA-mRNA network acts to contribute to certain effects to CHD such as myocardial hypertrophy, myocardial fibrosis, and heart failure. TCM contains constituents that act against CHD by antiatherosclerosis and apoptosis inhibition action, cardiac and cardiomyocyte protection, and these components also promote cell growth and protection of the vascular system by regulating miRNAs. Therefore, we consider that the circRNA-miRNA-mRNA network may be a new regulatory mechanism for the effective treatment of CHD by TCM.
机译:近年来,中国在中国冠心病(CHD)有关的发病率和死亡率增加。许多临床经验和研究表明,中医(TCM)在CHD的预防,治疗和预后起着重要作用。然而,TCM治疗CHD治疗的机制尚未阐明。 CircRNA-miRNA-mRNA网络由MiRNA组成,MiRNA由CircrNA竞争性地束缚,MiRNA调节mRNA的转录水平。通过文献综述,我们发现Circrna-miRNA-mRNA网络起作用对CHD的某些效果有助于心肌肥大,心肌纤维化和心力衰竭。 TCM含有通过抗炎症和凋亡抑制作用,心肌和心肌细胞保护作用的成分,并且这些组分还通过调节miRNA来促进细胞生长和对血管系统的保护。因此,我们认为Circrna-miRNA-mRNA网络可能是通过TCM有效治疗CHD的新调节机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号